Results 81 to 90 of about 173,499 (304)

SERUM PROLACTIN LEVEL IN ACNE PATIENTS VERSUS CONTROL GROUP: STUDY ON 14 TO 35 YEARS OLD WOMEN

Journal of Research in Medical Sciences, 2002
Introduction. Androgens have a main role in acne pathogenesis. The interaction between prolactin and androgens generate the hypothesis of prolactin role in acne pathogenesis. Methods.
G FAGHIHI, A SADEGHI NIA, M KEIVANFAR
doaj  

Do prolactin and its receptor play a role in alopecia areata?

Indian Journal of Dermatology, 2018
Context: Studying the link between prolactin and autoimmunity has gained much ground over the past years. Its role played in alopecia areata (AA) is not clear yet, as previous reports yielded controversial results.
Samar M El Tahlawi, Nermeen H El Eishi, Rima K Kahhal, Rehab A Hegazy, Ghada M El Hanafy, Rania M Abdel Hay, Olfat G Shaker   +6 more
doaj   +1 more source

Tryptophan research in panic disorder. [PDF]

, 2008
A considerable body of evidence suggests the involvement of serotonin neurotransmission in the pathogenesis of panic disorder. Research on pathways and functions of tryptophan, an essential amino acid converted into serotonin, may advance our ...
Maron, E, Nutt, DJ, Shlik, J
core   +5 more sources

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source

Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy

JACC: Basic to Translational Science, 2019
Summary: The etiology of peripartum cardiomyopathy remains unknown. One hypothesis is that an increase in the 16-kDa form of prolactin is pathogenic and suggests that breastfeeding may worsen peripartum cardiomyopathy by increasing prolactin, while ...
Agnes Koczo, MD, Amy Marino, MD, Arun Jeyabalan, MD, Uri Elkayam, MD, Leslie T. Cooper, MD, James Fett, MD, MPH, Joan Briller, MD, Eileen Hsich, MD, Lori Blauwet, MD, Charles McTiernan, PhD, Penelope A. Morel, MD, Karen Hanley-Yanez, BS, Dennis M. McNamara, MD, MS, Dennis M McNamara, MD, James D. Fett, MD, Jessica Pisarcik, RN, BSN, Charles McTiernan, PhD, Karen Hanley-Yanez, BS, John Gorcsan, III, MD, Erik Schelbert, MD, Rami Alharethi, MD, Kismet Rasmusson, CRNP, Kim Brunisholz, Amy Butler, BS, CCRP, Deborah Budge, A.G. Kfoury, MD, Benjamin Horne, PhD, Joe Tuinei, Heather Brown, Julie Damp, MD, Allen J. Naftilan, MD, Jill Russell, RN, MSN, Darla Freehardt, LPN, BS, CCRP, Eileen Hsich, MD, Cynthia Oblak, CCRC, Greg Ewald, MD, Donna Whitehead, RN, Jean Flanagan, RN, Anne Platts, Uri Elkayam, MD, Jorge Caro, MPH, Stephanie Mullin, RN, Michael M. Givertz, MD, M. Susan Anello, RN, BS, Navin Rajagopalan, MD, David Booth, MD, Tiffany Sandlin, RN, Wendy Wijesiri, RN, Leslie T. Cooper, MD, Lori A. Blauwet, MD, Joann Brunner, RN, Mary Phelps, Ruth Kempf, Kalgi Modi, MD, Tracy Norwood, Joan Briller, MD, Decebal Sorin Griza, MD, G. Michael Felker, MD, Robb Kociol, MD, Patricia Adams, RN, Gretchen Wells, MD, Vinay Thohan, MD, Deborah Wesley-Farrington, RN, BSN, CCRC, CCA, Sandra Soots, RN, CCRC, Richard Sheppard, MD, Caroline Michel, MD, Nathalie Lapointe, RN, PhD, Heather Nathaniel, Angela Kealey, MD, Marc Semigran, MD, Maureen Daher, RN, John Boehmer, MD, David Silber, MD, Eric Popjes, MD, Patricia Frey, RN, Todd Nicklas, RN, Jeffrey Alexis, MD, Lori Caufield, RN, BSN, CCRC, John W. Thornton, III, MD, Mindy Gentry, MD, Vincent J.B. Robinson, MBBS, Gyanendra K. Sharma, MD, Joan Holloway, BS, Maria Powell, LPN, CCRC, David Markham, MD, Mark Drazner, MD, Lynn Fernandez, RN, Mark Zucker, MD, David A. Baran, MD, Martin L. Gimovsky, MD, Natalia Hochbaum, MD, Bharati Patel, RN, CCRC, Laura Adams, RN, BSN, Gautam Ramani, MD, Stephen Gottlieb, MD, Shawn Robinson, MD, Stacy Fisher, MD, Joanne Marshall, BSN, MS, Jennifer Haythe, MD, Donna Mancini, MD, Rachel Bijou, MD, Maryjane Farr, MD, Marybeth Marks, Henry Arango, Biykem Bozkurt, MD, PhD, FACC, FAHA, Mariana Bolos, Paul Mather, MD, Sharon Rubin, MD, Raphael Bonita, MD, Susan Eberwine, RN, Hal Skopicki, MD, PhD, Kathleen Stergiopoulos, MD, Ellen McCathy-Santoro, MD, Jennifer Intravaia, RN, CCRCII, Elizabeth Maas, Jordan Safirstein, MD, Audrey Kleet, RN, MS, ACNP-BC, CCRN, CCTC, Nancy Martinez, RN, Christine Corpoin, RN, Donna Hesari, RN, Sandra Chaparro, MD, Laura J. Hudson, MA, MPH, CCRC, Jalal K. Ghali, MD, Zora Injic, RN, BSc, MSA, Ilan S. Wittstein, MD   +124 more
doaj   +1 more source

Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial [PDF]

, 2001
OBJECTIVES: To determine whether thyroxine treatment is effective in patients with symptoms of hypothyroidism but with thyroid function tests within the reference range, and to investigate the effect of thyroxine treatment on psychological and physical ...
Davidson, K.M., Kelly, C.J.G., Marshall, K., McLaren, E.H., McMahon, A.D., Pollock, M.A., Sturrock, A.   +6 more
core   +2 more sources

3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)‐deficient rats lacking serotonin in the central nervous system

British Journal of Pharmacology, EarlyView.
Background and Purpose 3,4‐Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, is a psychostimulant with entactogenic properties and known to induce arousal and euphoria. As an amphetamine derivate, MDMA acts on the monoamine systems in the brain and stimulates release of dopamine (DA), noradrenaline (NA) and serotonin (5‐HT), yet their ...
Tianhua Wang, Rainer K. W. Schwarting, Markus Wöhr   +2 more
wiley   +1 more source

The prolactin receptor: Diverse and emerging roles in pathophysiology

Journal of Clinical & Translational Endocrinology, 2015
Investigations over two decades have revised understanding of the prolactin hormone. Long thought to be merely a lactogenic hormone, its list of functions has been extended to include: reproduction, islet differentiation, adipocyte control and immune ...
Caroline M. Gorvin
doaj   +1 more source

A Retrospective Study on the Impact of Primary Aldosteronism in Pregnancy (H.A.P.P.I. Study Group)

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Primary aldosteronism (PA) is a common cause of hypertension in young women. However, there is a paucity of data regarding its impact during pregnancy. The primary objective of this study was to describe the occurrence of hypertensive disorders of pregnancy (HDP) in PA.
Diana Oprea, Frédérique Lefrançois, Matthieu St‐Jean, Anne‐Marie Côté, Marie‐Ève Roy‐Lacroix, Mandy Malick, Pierre‐Luc Mallet, Nadine Sauvé   +7 more
wiley   +1 more source

Are prolactin serum levels and coronary artery atherosclerosis correlated in postmenopausal women? A cross-sectional study

Türk Kardiyoloji Derneği Arşivi, 2019
Objective: Prolactin is correlated with some conditions that predispose individuals to atherosclerosis. Prolactin receptors have been found in atherosclerotic plaques.
Alireza Amirzadegan, Elnaz Salimi, Ali Hosseinsabet   +2 more
doaj   +1 more source